Skip to content

American CryoStem Corporation: 10-Q filed 2019-05-20

What American CryoStem Corporation reported in its quarterly report filed 2019-05-20 (fiscal Q2 2019): 36 published measures, 102 facts as tagged in accession 0001019056-19-000306.

This filing

Form
10-Q (quarterly report)
Filed
2019-05-20
Fiscal period
fiscal Q2 2019
Accession
0001019056-19-000306 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; a measure with a published history links to it, and the history shows the latest-filed value per period. All American CryoStem Corporation filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

PeriodValueUnitDays
At 2019-03-311,267,711USD
At 2018-09-301,266,425USD

Total liabilities

Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.

PeriodValueUnitDays
At 2019-03-312,234,528USD
At 2018-09-301,966,871USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

PeriodValueUnitDays
At 2019-03-31-966,817USD
At 2018-09-30-700,446USD
At 2018-03-31-615,193USD
At 2017-09-30-1,021,558USD

Cash and cash equivalents

Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.

PeriodValueUnitDays
At 2019-03-3119,550USD
At 2018-09-3068,320USD
At 2018-03-31323,683USD
At 2017-09-30410,342USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

PeriodValueUnitDays
2019-01-01 to 2019-03-31-352,103USD90
2018-10-01 to 2019-03-31-646,533USD182
2018-01-01 to 2018-03-31-207,703USD90
2017-10-01 to 2018-03-31-762,096USD182

Operating cash flow

Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.

PeriodValueUnitDays
2018-10-01 to 2019-03-31-366,945USD182
2017-10-01 to 2018-03-31244,815USD182

Capital expenditure payments

Cash payments to acquire property, plant and equipment. This taxonomy concept does not capture every form of investment or acquisition.

PeriodValueUnitDays
2018-10-01 to 2019-03-3125,678USD182
2017-10-01 to 2018-03-3127,470USD182

Revenue

Revenue under this specific accounting concept. A missing value is not zero; filers can use other revenue concepts.

PeriodValueUnitDays
2019-01-01 to 2019-03-3144,320USD90
2018-10-01 to 2019-03-31159,711USD182
2018-01-01 to 2018-03-31240,583USD90
2017-10-01 to 2018-03-31779,849USD182

Financing cash flow

Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.

PeriodValueUnitDays
2018-10-01 to 2019-03-31351,973USD182
2017-10-01 to 2018-03-3113,966USD182

Investing cash flow

Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.

PeriodValueUnitDays
2018-10-01 to 2019-03-31-33,798USD182
2017-10-01 to 2018-03-31-347,140USD182

Retained earnings or deficit

Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.

PeriodValueUnitDays
At 2019-03-31-14,783,210USD
At 2018-09-30-14,136,677USD

Income tax expense or benefit

Current and deferred income tax expense or benefit for continuing operations. This accounting expense differs from cash taxes paid.

PeriodValueUnitDays
2019-01-01 to 2019-03-310USD90
2018-10-01 to 2019-03-310USD182
2018-01-01 to 2018-03-310USD90
2017-10-01 to 2018-03-310USD182

Net property, plant and equipment

Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.

PeriodValueUnitDays
At 2019-03-31256,936USD
At 2018-09-30244,707USD

Share-based compensation expense

Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.

PeriodValueUnitDays
2019-01-01 to 2019-03-3130,121USD90
2018-10-01 to 2019-03-3160,242USD182
2018-01-01 to 2018-03-310USD90
2017-10-01 to 2018-03-31549,588USD182

Operating income or loss

Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.

PeriodValueUnitDays
2019-01-01 to 2019-03-31-323,353USD90
2018-10-01 to 2019-03-31-584,713USD182
2018-01-01 to 2018-03-31-164,849USD90
2017-10-01 to 2018-03-31-613,264USD182

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

PeriodValueUnitDays
At 2019-03-31351,871USD
At 2018-09-30369,057USD

Interest expense

Borrowing costs recognized as interest expense. This is distinct from cash interest paid and may not include every capitalized borrowing cost.

PeriodValueUnitDays
2019-01-01 to 2019-03-3116,251USD90
2018-10-01 to 2019-03-3132,704USD182
2018-01-01 to 2018-03-3122,670USD90
2017-10-01 to 2018-03-3152,211USD182

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

PeriodValueUnitDays
At 2019-03-311,205,048USD
At 2018-09-301,112,110USD

Net current accounts receivable

Current customer receivables after the allowance for credit loss. The balance is not cash collected or a guarantee of collection.

PeriodValueUnitDays
At 2019-03-31305,283USD
At 2018-09-30217,318USD

Operating expenses

Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.

PeriodValueUnitDays
2019-01-01 to 2019-03-31346,963USD90
2018-10-01 to 2019-03-31718,751USD182
2018-01-01 to 2018-03-31326,321USD90
2017-10-01 to 2018-03-311,230,628USD182

Net inventory

Inventory carrying amount after applicable valuation and LIFO reserves. It does not establish realizable selling proceeds or inventory turnover without other inputs.

PeriodValueUnitDays
At 2019-03-3127,038USD
At 2018-09-3033,698USD

Gross profit

Revenue less the costs directly attributed to the goods or services sold. It precedes other operating expenses and is not net income.

PeriodValueUnitDays
2019-01-01 to 2019-03-3123,610USD90
2018-10-01 to 2019-03-31134,038USD182
2018-01-01 to 2018-03-31161,472USD90
2017-10-01 to 2018-03-31617,364USD182

Cost of revenue

Costs attributed to goods produced and sold and services provided during the period. This is not the sum of every operating expense.

PeriodValueUnitDays
2019-01-01 to 2019-03-3120,710USD90
2018-10-01 to 2019-03-3125,673USD182
2018-01-01 to 2018-03-3179,111USD90
2017-10-01 to 2018-03-31162,485USD182

Common shares outstanding

Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.

PeriodValueUnitDays
At 2019-03-3149,230,582shares
At 2018-09-3048,196,210shares

Additional paid-in capital

Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.

PeriodValueUnitDays
At 2019-03-3113,767,161USD
At 2018-09-3013,388,034USD

Accumulated depreciation on property, plant and equipment

Cumulative depreciation, depletion and amortization recorded against property, plant and equipment. It measures cost allocation to date, not physical wear or market value.

PeriodValueUnitDays
At 2019-03-31300,521USD
At 2018-09-30287,071USD

Pre-tax income or loss from continuing operations

Income or loss from continuing operations before income taxes and noncontrolling interests. It excludes discontinued operations and is not net income.

PeriodValueUnitDays
2019-01-01 to 2019-03-31-352,103USD90
2018-10-01 to 2019-03-31-646,533USD182
2018-01-01 to 2018-03-31-207,703USD90
2017-10-01 to 2018-03-31-762,096USD182

General and administrative expense

General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.

PeriodValueUnitDays
2019-01-01 to 2019-03-31175,386USD90
2018-10-01 to 2019-03-31364,879USD182
2018-01-01 to 2018-03-31127,381USD90
2017-10-01 to 2018-03-31304,812USD182

Depreciation expense

Depreciation recognized for the period under this concept. It is a noncash allocation of asset cost and may exclude amortization and depletion reported elsewhere.

PeriodValueUnitDays
2019-01-01 to 2019-03-316,728USD90
2018-10-01 to 2019-03-3113,450USD182
2018-01-01 to 2018-03-3120,976USD90
2017-10-01 to 2018-03-3126,959USD182

Depreciation, depletion and amortization

Combined depreciation, depletion and amortization for the period. A noncash allocation of asset cost, not a measure of maintenance spending.

PeriodValueUnitDays
2018-10-01 to 2019-03-3115,327USD182
2017-10-01 to 2018-03-3130,408USD182

Amortization of intangible assets

Amortization recognized on finite-lived intangible assets. It follows acquisition accounting and does not indicate the intangibles are losing usefulness at that rate.

PeriodValueUnitDays
2019-01-01 to 2019-03-31928USD90
2018-10-01 to 2019-03-311,877USD182
2018-01-01 to 2018-03-31928USD90
2017-10-01 to 2018-03-313,449USD182

Interest paid, net

Cash interest paid during the period, net of amounts capitalized where the filer reports it that way. It differs from interest expense recognized.

PeriodValueUnitDays
2018-10-01 to 2019-03-316,169USD182
2017-10-01 to 2018-03-313,465USD182

Income taxes paid, net

Cash income taxes paid net of refunds during the period. It differs from income tax expense and can reflect prior years and estimated payments.

PeriodValueUnitDays
2018-10-01 to 2019-03-310USD182
2017-10-01 to 2018-03-310USD182

Proceeds from issuing common stock

Cash received from issuing common stock during the period. It is gross of costs only where the filer reports it so, and it does not include noncash issuances.

PeriodValueUnitDays
2018-10-01 to 2019-03-31270,000USD182
2017-10-01 to 2018-03-310USD182

Change in accounts receivable

The cash flow adjustment for the change in receivables during the period. A positive value under this concept means receivables grew and reduced operating cash flow.

PeriodValueUnitDays
2018-10-01 to 2019-03-31-93,600USD182
2017-10-01 to 2018-03-317,943USD182

Change in inventories

The cash flow adjustment for the change in inventories during the period. A positive value under this concept means inventory grew and reduced operating cash flow.

PeriodValueUnitDays
2018-10-01 to 2019-03-316,660USD182
2017-10-01 to 2018-03-31-3,365USD182

Inspect the source

Entity
American CryoStem Corporation / CIK 0001468679
Captured
SEC response SHA-256
989d6940bd454aa52ced7069bb00d7059fedcf39f5e0d0c504f9fa725c0cf4b0

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001468679.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))